We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid HDR Prostate Brachytherapy Treatment for Prostate Cancer Requires only Several Minutes of Radiation Exposure

By HospiMedica International staff writers
Posted on 26 Apr 2016
A new innovative radiation treatment for prostate cancer called High Dose Rate (HDR) prostate brachytherapy can deliver a precise radiation dose within several minutes, and is then removed immediately afterwards, minimizing potential side effects and damage to surrounding healthy tissue.

The HDR brachytherapy treatment is a one-hour long outpatient procedure that includes a preliminary Computed Tomography (CT) scan, in-depth radiation treatment planning, and a personalized radiation dose delivered by a robotic system. More...
The procedure is performed by a radiation oncologist together with an urologist. HDR brachytherapy can be combined a short course of external beam radiation, for more aggressive prostate cancers, so that a higher radiation dose can be delivered to the prostate gland.

The Loyola University Medical Center (Maywood, IL, USA) offers the new HDR procedure as well as radical prostatectomy, proton therapy, Image-Guided Intensity-Modulated Radiation Therapy (IMRT), and LDR brachytherapy. While each of the treatment methods has its advantages and disadvantages, and has been shown to be safe and effective, HDR brachytherapy is a cutting-edge treatment that is convenient, reliable, and customizable.

Loyola radiation oncologist Abhishek Solanki, MD, said, “What sets HDR brachytherapy apart is the ability to sculpt the radiation dose to reliably avoid healthy organs, such as the bladder, rectum and urethra. Since the radiation source is removed immediately after completion of treatment, patients do not have to take radiation precautions after they leave the hospital.”

Related Links:
Loyola University Medical Center


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Resorbable Bovine Collagen Membrane
GenDerm
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.